Search for: "Eli Lilly "
Results 1801 - 1820
of 2,131
Sort by Relevance
|
Sort by Date
24 Oct 2008, 1:09 pm
As reported by the Indianapolis Star, Eli Lilly and Co. announced Tuesday that it is prepared to pay more than $1.4 billion to settle state and federal investigations related to the drugmaker's marketing of the antipsychotic medication Zyprexa. [read post]
21 Oct 2008, 6:21 am
Here is a partial list: Prasugrel, a blood thinner from Eli Lilly and Daiichi Sankyo. [read post]
20 Oct 2008, 5:39 pm
Why do I smile? [read post]
17 Oct 2008, 3:06 pm
Eli Lilly & Co. has agreed to pay $62 million to some states, to settle claims it improperly marketed Zyprexa, its top-selling drug, to patients who did not have schizophrenia or bipolar disorder, its only approved uses. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
16 Oct 2008, 8:19 pm
We had previously written a blog about Byetta developed by Eli Lilly and Company and Amylin Pharmaceuticals, Inc. [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas,… [read post]
15 Oct 2008, 9:43 am
High Court (Commercial Cout) Office of Fair Trading v Abbey National Plc & Ors [2008] EWHC 2325 (Comm) (08 October 2008) High Court (Patents Court) Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Company Ltd [2008] EWHC 2345 (Pat) (13 October 2008) Source: www.bailii.org [read post]
15 Oct 2008, 8:38 am
AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Novartis, Merck, and 3M.Less than six months after this… [read post]
14 Oct 2008, 3:35 am
Eli Lilly and Company became the first major drug maker to commit to physician payment disclosure, representing the newest example of the pharmaceutical industry's openness about its practices. [read post]
13 Oct 2008, 6:55 pm
Major drug company settled for big cash and agreed to change some of its practices after questions were raised about its top-selling anti-psychotic drug. [read post]
13 Oct 2008, 2:41 pm
Hot off the press comes the ruling today of Mr Justice Floyd (Patents Court, England and Wales) in Dr Reddy's Laboratories (UK) Ltd v Eli Lilly and Company Ltd [2008] EWHC 2345 (Pat). [read post]
10 Oct 2008, 11:45 pm
Eli Lilly agreed to stop all off-label promotions for Zyprexa and to give its medical staff -- not its marketing department -- the final decision on all medical references and letters about the drug. [read post]
10 Oct 2008, 3:22 pm
In fact in the early nineties, parent, Eli Lilly suffered from its sown problems, such as expiring patents for revenue generating drugs, and a general failure to keep pace with its competitors. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist'… [read post]
10 Oct 2008, 11:03 am
Eleven years after the drug hit the market and twelve years after a large study indicated that use of the drug increased risks for weight gain and diabetes, pharmaceutical manufacturer Eli Lilly has finally expanded its warning labels on its best selling product Zyprexa. [read post]
10 Oct 2008, 1:15 am
Thirty-three states will split a combined $62 million under a settlement with Eli Lilly over the drug maker's marketing of Zyprexa. [read post]
8 Oct 2008, 4:25 pm
Here's an excerpt: Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly... [read post]
8 Oct 2008, 4:13 pm
Updating earlier ILB Lilly Zyprexa entries, Tom Murphy and Marley Seaman of the Associated Press report today in a story that begins:Drugmaker Eli Lilly & Co. cleared another legal cloud hanging over its top-selling drug Zyprexa when it announced a $62 million settlement Tuesday with several states, including Illinois, but several other storms are still brewing for the anti-psychotic medication. [read post]
8 Oct 2008, 6:35 am
Zyprexa is Lilly's biggest product, with global sales of $4.76 billion in 2007.The settlement with 32 states and the District of Columbia ends an 18-month investigation of the Indianapolis-based company, which had been accused of promoting the drug for unapproved off-label uses and of playing down side effects such as weight gain, which can increase the risk for diabetes.Source here. [read post]
